Friday, 13 Sep 2019

You are here

Funding for Rheumatology Research in Decline

The Rheumatology Research Foundation and Rheumatology News report that research projects funded by the National Institutes of Health (NIH) dropped by 52% from 2010 to 2014, while the number funded by private foundations fell by 29% over that period.

In 2010, 826 projects were funded by the NIH to ACR members. By 2014, that number was down to 515 (52% decline). During the same timeframe, private foundation funding to ACR contacts went from 90 to 64 funded projects (29% fall).

In that same time period, NIH funding went from $1.16 billion to $686 million while investment by private foundations dropped from $20.7 million in 2010 to $13.6 million in 2014.

The RRF reports that funding for osteoporosis dropped by 31%, while arthritis and lupus were down 22% and Lyme disease spending fell by 21%. Federal funding of autoimmune disease research was down by 16%. Funding was up for scleroderma (14%) and fibromyalgia (11%), although the total spending for these two areas was much lower than for the others, with 2014 scleroderma funding ($24 million) coming to about a tenth of that for arthritis ($239 million).

These trends will strain the efforts of academic investigators and put greater pressure on the ACR and RFF to foster new revenue streams for rheumatology research.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Rise in Fatty Liver Disease Linked to Obesity and Diabetes

Gut has published population results from NHANES population study showing that the prevalence of fatty liver disease is rising in the US and is driven by obesity and diabetes.

Employed Physicians Outnumber Self-Employed

For the first time in the United States, employed physicians outnumber self-employed physicians, according to a newly updated study on physician practice arrangements by the American Medical Association (AMA). This milestone marks the continuation of a long-term trend that has slowly shifted the distribution of physicians away from ownership of private practices.

 

Dr. Harold E. Paulus (1929-2019)

Dr. Harold “Hal” Paulus lives in the annals of Rheumatology as a major contributor, mentor, researcher and clinical trialist. He passed away last week, one day after his 89th birthday. I met Dr. Paulus as a fellow in 1985, when he easily included me in his discussions and research on rheumatoid arthritis. I admired his easy demeanor, wry humor and every man character. Most remark on his calm recessive and kind personality that was complemented by a body of work that was large, impactful and usually at the cutting edge. Many of Dr. Paulus’ colleagues and friends have contributed their testimonies and fond memories of this great man.

RheumNowLive On Demand: The History of Steroids - Dr. Eric Matteson

A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.

Mourning the Loss of NIAMS Director Stephen Katz, MD, PhD

The following tribute to the late Dr. Steven Katz appeared on the NIH website.